RecruitingNCT07156370

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

Studying OBSOLETE: Cushing syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shanghai 6th People's Hospital
Enrollment: 500 enrolled
Eligibility: 18-80 years · All sexes
Timeline: 2025 – 2027

Study locations (1)

Shanghai Sixth People's Hospital, Shanghai, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07156370 on ClinicalTrials.gov

Other trials for OBSOLETE: Cushing syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07296484
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Sparrow Pharmaceuticals
RECRUITINGPHASE1, PHASE2NCT07350707
Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome
Peking Union Medical College Hospital
ACTIVE NOT RECRUITINGNANCT05315388
Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá
Jeadran N. Malagón-Rojas
ACTIVE NOT RECRUITINGNCT05382156
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
RECORDATI GROUP
RECRUITINGNANCT05368090
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Haukeland University Hospital

See all trials for OBSOLETE: Cushing syndrome →

← Back to all trials